Societal CDMO: Support From Concept to Commercialization
Societal CDMO subject matter experts explore trends in pharmaceutical drug development and highlight capabilities of the US-based pharmaceutical CDMO company.
Interviews featuring:
- Christopher Ellis, Business Development Director, CTS, at Societal™ CDMO
- Madeline McCarthy, Business Development Director, Sterile Fill Finish, at Societal™ CDMO
- Scott Rizzo, Senior Vice President and Chief Operating Officer at Societal™ CDMO
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
